|Bid||90.00 x 800|
|Ask||91.36 x 1300|
|Day's Range||90.00 - 93.04|
|52 Week Range||67.98 - 141.98|
|Beta (5Y Monthly)||1.74|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
OPKO Health's (OPK) third-quarter results are likely to reflect solid performance from Products segment and RAYALDEE.
Livongo Health's (LVGO) third-quarter results are likely to reflect growth in core Livongo for Diabetes solution.
Baxter's (BAX) third-quarter performance is likely to reflect growth in its Acute Therapies business.